about
Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protectionCross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.Pseudotype-based neutralization assays for influenza: a systematic analysis.Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 SubtypeActivation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian virusesDiscordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals.Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation.Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro.Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays.Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.An optimised method for the production of MERS-CoV spike expressing viral pseudotypes.Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses.The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays.Pseudotype Neutralization Assays: From Laboratory Bench to Data AnalysisThe application of pseudotypes to influenza pandemic preparednessDevelopment and use of Lentiviral Vectors Pseudotyped with Influenza B Haemagglutinins: application to vaccine immunogenicity, mAb potency and sero-surveillance studiesNext Generation Vaccines for Infectious Diseases.Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free MediaOptimizing lentiviral vector transduction of hematopoietic stem cells for gene therapy
P50
Q30209769-A7034CB4-5533-4B32-B369-530FCF0F273BQ30369825-726AF688-C824-4208-A8ED-ED65C6ADC10BQ30374662-7CD57DA4-27A5-4689-9EDC-D47A9635D43DQ30376605-7323D356-4AE2-4123-81D9-88C42FAEB19CQ30384745-E1B5CAEE-30E0-43A2-860F-A9C74B42D7AFQ30427946-E4FD55A6-3233-4953-BCF2-2E1BB0F23BD3Q30429267-7545999C-5168-4436-87D9-A2F737D7A570Q33809686-7D608BC3-A203-4D21-BE15-E648AA828C02Q34683447-94B4DBE9-4069-43E1-9B8E-E3379AFA10EAQ37336363-9AB043F3-B4CA-4360-B078-5B7FAF816B1BQ40116170-0363D718-2E7A-41AB-8388-77576970820CQ40388013-F63F1E0B-0B3D-4373-B819-0D4F8BFD761BQ40972609-9ED0697F-BA82-4D1F-93CC-C8A93DF3C30AQ41110675-5B8BCD26-B893-431E-B4CC-575C58D94C82Q41525616-B0D37EB3-5340-46A2-8697-B1128C914620Q41930591-455CA742-C767-425F-8113-E14FEB5AE279Q58382355-3DE08E3B-F1F2-497D-A945-383638645567Q58382401-D9AB1E81-23AD-4F13-BE75-D24AD3977B49Q62898056-FEDAC669-BFEB-400D-93AF-C0CEAB6B6FE8Q64996324-60E654D5-A34B-4C8F-82C7-61193E49AB65Q92345079-2F6693D5-5C28-4E22-956A-1F39B67D3946Q93270633-BCFD6EDD-FE51-48A5-AC47-D5B164EA074E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Francesca Ferrara
@ast
Francesca Ferrara
@en
Francesca Ferrara
@es
Francesca Ferrara
@nl
type
label
Francesca Ferrara
@ast
Francesca Ferrara
@en
Francesca Ferrara
@es
Francesca Ferrara
@nl
prefLabel
Francesca Ferrara
@ast
Francesca Ferrara
@en
Francesca Ferrara
@es
Francesca Ferrara
@nl
P106
P1153
56237449900
P21
P31
P496
0000-0002-4973-1520